Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal, Gerard Sanacora, Ronald S. Duman
Biological Psychiatry (2013) Vol. 73, Iss. 12, pp. 1133-1141
Open Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches
Hannah R. Snyder, Akira Miyake, Benjamin L. Hankin
Frontiers in Psychology (2015) Vol. 6
Open Access | Times Cited: 823
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Chun Yang, Yukihiko Shirayama, Ji‐chun Zhang, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 9, pp. e632-e632
Open Access | Times Cited: 529
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1469-1658
Open Access | Times Cited: 445
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett, et al.
Pharmacology & Therapeutics (2018) Vol. 197, pp. 83-102
Closed Access | Times Cited: 421
Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression
Christoph Kraus, Eero Ċastrén, Siegfried Kasper, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 77, pp. 317-326
Closed Access | Times Cited: 380
Lower synaptic density is associated with depression severity and network alterations
Sophie Holmes, Dustin Scheinost, Sjoerd J. Finnema, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 378
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Annual Review of Medicine (2014) Vol. 66, Iss. 1, pp. 509-523
Open Access | Times Cited: 366
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal, Chadi G. Abdallah, Gerard Sanacora, et al.
Neuron (2019) Vol. 101, Iss. 5, pp. 774-778
Open Access | Times Cited: 357
R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji‐chun Zhang, Su‐Xia Li, Kenji Hashimoto
Pharmacology Biochemistry and Behavior (2013) Vol. 116, pp. 137-141
Closed Access | Times Cited: 321
High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation
Sophie Dutheil, Kristie T. Ota, Eric S. Wohleb, et al.
Neuropsychopharmacology (2015) Vol. 41, Iss. 7, pp. 1874-1887
Open Access | Times Cited: 300
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 952-964
Open Access | Times Cited: 287
Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Ji‐chun Zhang, Jin Wu, Yūkō Fujita, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 4
Open Access | Times Cited: 271
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman, Ronald S. Duman
Neuroscience Letters (2015) Vol. 601, pp. 20-29
Open Access | Times Cited: 241
Serotonin: A never-ending story
Berend Olivier
European Journal of Pharmacology (2014) Vol. 753, pp. 2-18
Open Access | Times Cited: 230
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 361, Iss. 1, pp. 9-16
Open Access | Times Cited: 229
Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans
Suresh Muthukumaraswamy, Alexander D. Shaw, Laura E. Jackson, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 33, pp. 11694-11706
Open Access | Times Cited: 223
Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
Chun Yang, Qian Ren, Youge Qu, et al.
Biological Psychiatry (2017) Vol. 83, Iss. 1, pp. 18-28
Open Access | Times Cited: 222
The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Gianluca Serafini, Robert H. Howland, Fabiana Rovedi, et al.
Current Neuropharmacology (2014) Vol. 12, Iss. 5, pp. 444-461
Open Access | Times Cited: 205
NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS
Ronald S. Duman
Depression and Anxiety (2014) Vol. 31, Iss. 4, pp. 291-296
Open Access | Times Cited: 196
Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Chun Yang, Youge Qu, Yūkō Fujita, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 12
Open Access | Times Cited: 195
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung‐Ping Su, Mu‐Hong Chen, Cheng‐Ta Li, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 13, pp. 2482-2492
Open Access | Times Cited: 182
Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective
John H. Krystal, Alan Anticevic, Genevieve Yang, et al.
Biological Psychiatry (2017) Vol. 81, Iss. 10, pp. 874-885
Open Access | Times Cited: 178
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 8, pp. 689-697
Open Access | Times Cited: 175
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 161
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
Roger S. McIntyre, Isabelle P. Carvalho, Leanna M.W. Lui, et al.
Journal of Affective Disorders (2020) Vol. 276, pp. 576-584
Closed Access | Times Cited: 147
Page 1 - Next Page

Scroll to top